Characterizing the Regional Structural Difference of the Brain between Tau Transgenic (rTg4510) and Wild-Type Mice Using MRI. - Zhiyong Xie; Dewen Yang; Diane Stephenson; Daniel Morton; Carol D. Hicks; Tracy M. Brown; Thomas Bocan (MICCAI (1), 2010)

Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510). - Dewen Yang; Zhiyong Xie; Diane Stephenson; Daniel Morton; Carol D. Hicks; Tracy M. Brown; Renuka Sriram; Sharon O'Neill; David Raunig; Thomas Bocan (NeuroImage, 2011)

Identifying and characterising sources of variability in digital outcome measures in Parkinson's disease. - George Roussos; Teresa Ruiz-Herrero; Derek L. Hill; Ariel V. Dowling; Martijn L. T. M. Müller; Luc J. W. Evers; Jackson Burton; Adrian Derungs; Katherine Fisher; Krishna Praneeth Kilambi; Nitin Mehrotra; Roopal Bhatnagar; et al. (npj Digit. Medicine, 2022)

Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson's Disease. - Derek L. Hill; Diane Stephenson; Jordan Brayanov; Kasper Claes; Reham Badawy; Sakshi Sardar; Katherine Fisher; Susan J. Lee; Anthony Bannon; George Roussos; Tairmae Kangarloo; Viktorija Terebaite; et al. (Sensors, 2022)

Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD. - Tairmae Kangarloo; Robert D. Latzman; Jamie L. Adams; Ray Dorsey; Melissa A. Kostrzebski; Joan Severson; David Anderson; F. Horak; Diane Stephenson; Josh Cosman (Frontiers Digit. Health, 2024)